Geneva
After hearing desperate pleas from African diplomats, the World Trade Organization agreed this week to provide poor countries with inexpensive versions of patented drugs for AIDS and other diseases. African representatives gave a joint statement pointing out that more than 2 million Africans had died for lack of treatment since last December, when the drug issue became deadlocked at the WTO. The U.S., the leader among countries concerned about protecting patent rights, reversed course and agreed to allow the use of generics, with certain restrictions aimed at preventing resale of the cheap drugs in Western nations. Kenyan Ambassador Amina Chawahir Mohamed called the agreement “especially good news for the people of Africa.”
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Citizenship: Trump order blocked againFeature After the Supreme Court restricted nationwide injunctions, a federal judge turned to a class action suit to block Trump's order to end birthright citizenship
-
Loyalty tests: The purge at the FBIFeature Kash Patel is conducting polygraph tests on FBI agents to weed out anyone speaking badly about him
-
The all-seeing tech giantFeature Palantir's data-mining tools are used by spies and the military. Are they now being turned on Americans?
